Skip to content

Dr. Lupo Antonella

Orthoptist, Ophthalmology Assistant
FondazioneBietti_Lupo Antonella
Research line: Research Line of Glaucoma and anterior segment with ocular annexes
Research unit: RU Glaucoma
Simple Operating Unit: Simple Operating Unit Glaucoma and Hospital-Territory Integration 
Specialization: Orthoptist, Ophthalmology Assistant
Professional register: Register of Medical Radiology Technicians and of Technical, Rehabilitation and Prevention Health Professions of Rome and Province, No. 136 dated 18.02.2019

Practices at IRCCS Fondazione G.B. Bietti at the premises of Via Licenza 3 and Via di Santo Stefano Rotondo 6, Presidio Ospedaliero Britannico, Rome.

 

  • 2021: First-Level Master’s Degree in New Techniques and Strategies of Visual Rehabilitation, University of Rome “La Sapienza.”
  • May 2019: Advanced Course in Low Vision and Visual Rehabilitation in Adults: Certified Expert in Low Vision, International School of Optics and Optometry (S.I.O.O.).
  • 2016: First-Level Master’s Degree in Assistance in Ophthalmic Surgery, University of Rome “La Sapienza.”
  • 2014: Bachelor’s Degree in Orthoptics and Ophthalmology Assistance, University of Rome “Tor Vergata,” Faculty of Medicine and Surgery.

 

  • 2022 – present: Permanent employee as Orthoptist, Ophthalmology Assistant at IRCCS G.B. Bietti.
  • 2016 – 2021: Contract staff as Orthoptist, Ophthalmology Assistant at IRCCS G..B. Bietti.
  • Technical support activity for the scientific research of the Glaucoma Unit.

Sub-Investigator in the following clinical studies:

  • Modulation of neuronal connectivity along the optic pathways in glaucoma patients through treatment with oral citicoline solution: a multimodal morpho-functional study.

  • Efficacy and safety assessment of T4030 eye drops versus Ganfort® UD in ocular hypertensive or glaucomatous patients – LT4030-301.

  • Phase 3b study to evaluate the duration of effect of Bimatoprost SR in participants with open-angle glaucoma or ocular hypertension – TRITON 1698-301-007.

  • Basic human research study of novel glaucoma endpoints and identification of optimal patient populations for neuroprotection trials – CBASICHR0031.

  • Evaluation of spatial summation within the central 10 degrees of the visual field: development of a neural model for structure–function analysis.

  • Efficacy and 24-hour tolerability of preservative-free fixed combination tafluprost–timolol in glaucomatous or ocular hypertensive patients previously treated with latanoprost preserved with BAK: a 3-month prospective open-label study (HERO).

  • Evaluation of agreement in the diagnosis of glaucomatous visual field progression.

Skip to content